N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141827 |
| CAS No | NA |
| Mol.F. | C6H11N3O3 |
| Mol.Wt. | 173.17 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141828 |
| CAS No | NA |
| Mol.F. | C17H22N6O5 |
| Mol.Wt. | 390.40 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141829 |
| CAS No | NA |
| Mol.F. | C26H32ClN7O5 |
| Mol.Wt. | 558.04 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141830 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O3 |
| Mol.Wt. | 457.92 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141831 |
| CAS No | NA |
| Mol.F. | C16H20N4O3S |
| Mol.Wt. | 348.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141832 |
| CAS No | NA |
| Mol.F. | C29H35N7O4S |
| Mol.Wt. | 577.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141833 |
| CAS No | NA |
| Mol.F. | C19H29N5O5S2 |
| Mol.Wt. | 471.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141834 |
| CAS No | NA |
| Mol.F. | C17H19N4O3S |
| Mol.Wt. | 359.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141835 |
| CAS No | NA |
| Mol.F. | C20H26N5O5S2 |
| Mol.Wt. | 480.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141836 |
| CAS No | NA |
| Mol.F. | C16H22N4O3S |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141837 |
| CAS No | NA |
| Mol.F. | C7H8N4O2 |
| Mol.Wt. | 180.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141838 |
| CAS No | NA |
| Mol.F. | C12H13N3O6 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141839 |
| CAS No | NA |
| Mol.F. | C17H15N3O4 |
| Mol.Wt. | 325.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141840 |
| CAS No | NA |
| Mol.F. | C18H22N6O4 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141841 |
| CAS No | NA |
| Mol.F. | C17H20N6O6 |
| Mol.Wt. | 404.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141842 |
| CAS No | 145438-97-7 |
| Mol.F. | C7H10N6O3 |
| Mol.Wt. | 226.2 |
| INV STATUS | CUSTOM SYNTHESIS |